Published in BMC Public Health on June 06, 2013
Association between Socioeconomic Status and Cancer Screening in Koreans over 40 Years in Age Based on the 2010-2012 Korean National Health and Nutrition Examination Survey. Korean J Fam Med (2016) 0.83
Willingness and acceptability of cervical cancer screening among women living with HIV/AIDS in Addis Ababa, Ethiopia: a cross sectional study. Gynecol Oncol Res Pract (2015) 0.78
Microcredit participation and women's health: results from a cross-sectional study in Peru. Int J Equity Health (2015) 0.77
Examining the Cervical Screening Behaviour of Women Aged 50 or above and Its Predicting Factors: A Population-Based Survey. Int J Environ Res Public Health (2016) 0.75
Factors associated with participation in cervical cancer screening among young Koreans: a nationwide cross-sectional study. BMJ Open (2017) 0.75
Assessment of trends in socioeconomic inequalities in cancer screening services in Korea, 1998-2012. Int J Equity Health (2016) 0.75
Cancer statistics, 2000. CA Cancer J Clin (2000) 12.32
Validation of recall of breast and cervical cancer screening by women in an ethnically diverse population. Prev Med (2002) 3.34
Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. BMJ (2009) 2.77
Cervical screening and health inequality in England in the 1990s. J Epidemiol Community Health (2003) 2.67
Pap testing adherence among Vietnamese American women. Cancer Epidemiol Biomarkers Prev (2004) 1.42
Determinants of womens participation in cervical cancer screening trial, Maharashtra, India. Bull World Health Organ (2007) 1.39
Disparities in cervical cancer screening between Asian American and Non-Hispanic white women. Cancer Epidemiol Biomarkers Prev (2008) 1.16
Reduced likelihood of cancer screening among women in urban areas and with low socio-economic status: a multilevel analysis in Japan. Public Health (2005) 1.16
Sociodemographic gradients in breast and cervical cancer screening in Korea: the Korean National Cancer Screening Survey (KNCSS) 2005-2009. BMC Cancer (2011) 1.12
Barriers to cervical cancer screening in rural Mexico. Int J Gynecol Cancer (2002) 1.11
[Factors associated with cancer screening participation, Korea]. J Prev Med Public Health (2005) 1.08
Why do women participate in the English cervical cancer screening programme? J Health Econ (2006) 1.03
[Trend of socioeconomic inequality in participation in cervical cancer screening among Korean women]. J Prev Med Public Health (2007) 1.01
[Disparities in participation in health examination by socio-economic position among adult Seoul residents]. J Prev Med Public Health (2007) 1.00
Perceived benefits of cervical cancer screening among women attending Mahalapye District Hospital, Botswana. Asian Pac J Cancer Prev (2010) 0.97
Predicting the stages of adoption of cervical cancer screening among Korean women. Prev Med (2009) 0.95
Socio-economic disparities in behavioural risk factors for cancer and use of cancer screening services in Korean adults aged 30 years and older: the Third Korean National Health and Nutrition Examination Survey, 2005 (KNHANES III). Public Health (2010) 0.95
Breast and cervical cancer screening: associations with personal, spouse's, and combined smoking status. Cancer Epidemiol Biomarkers Prev (2000) 0.94
Cervical cancer screening among Thai women in Northern California. J Womens Health (Larchmt) (2008) 0.94
Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia). Cancer Causes Control (2006) 0.93
[Participation rate and related socio-demographic factors in the national cancer screening program]. J Prev Med Public Health (2005) 0.91
Trend in cervical cancer screening in Spain (2003-2009) and predictors of adherence. Eur J Cancer Prev (2012) 0.88
Improving adherence to regular pap smear screening among Asian women: a population-based study in Singapore. Health Educ Behav (2002) 0.87
Perceptions of risk factors for breast cancer and attitudes toward mammography among women who are current, ex- and non-smokers. Women Health (2002) 0.87
Enhancement of the cervical cancer screening program in Malaysia: a qualitative study. Asian Pac J Cancer Prev (2010) 0.86
Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010. Diabetes Metab (2011) 0.86
Screening for the major malignancies affecting women: current guidelines. Am J Obstet Gynecol (2001) 0.84
Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat (2009) 5.01
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat (2011) 4.21
Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci (2010) 3.79
Current status of thyroid cancer screening in Korea: results from a nationwide interview survey. Asian Pac J Cancer Prev (2011) 2.89
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys (2012) 2.80
Cancer statistics in Korea: incidence, mortality and survival in 2005. J Korean Med Sci (2009) 2.61
Overview of the National Cancer screening programme and the cancer screening status in Korea. Asian Pac J Cancer Prev (2011) 2.41
Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study. J Korean Med Sci (2013) 2.23
Breast cancer subtypes and survival in patients with brain metastases. Breast Cancer Res (2008) 1.95
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets. Nat Nanotechnol (2013) 1.92
Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy. Int J Radiat Oncol Biol Phys (2010) 1.88
Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer (2005) 1.86
Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma. Int J Radiat Oncol Biol Phys (2007) 1.77
Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatments. J Gastroenterol Hepatol (2011) 1.55
Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys (2007) 1.53
Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol (2007) 1.48
Hospital Acquisitions Before Healthcare Reform. J Healthc Manag (2015) 1.46
[The adverse effect of indirectly diagnosed portal hypertension on the complications and prognosis after hepatic resection of hepatocellular carcinoma]. Korean J Hepatol (2006) 1.43
Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2006) 1.33
The adoption of electronic medical records and decision support systems in Korea. Healthc Inform Res (2011) 1.33
Trends in socioeconomic disparities in organized and opportunistic gastric cancer screening in Korea (2005-2009). Cancer Epidemiol Biomarkers Prev (2010) 1.30
Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis. Int J Radiat Oncol Biol Phys (2013) 1.29
Gastric cancer screening in Korea: report on the national cancer screening program in 2008. Cancer Res Treat (2011) 1.28
Ethanol production from rice straw using optimized aqueous-ammonia soaking pretreatment and simultaneous saccharification and fermentation processes. Bioresour Technol (2009) 1.28
Performance of different gastric cancer screening methods in Korea: a population-based study. PLoS One (2012) 1.26
[Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database]. J Prev Med Public Health (2009) 1.23
Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. J Gastroenterol Hepatol (2012) 1.22
Results of colorectal cancer screening of the national cancer screening program in Korea, 2008. Cancer Res Treat (2010) 1.22
Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules: comparison in efficacy according to nodule size. Thyroid (2009) 1.18
Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy. Radiother Oncol (2008) 1.18
A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea. Liver Int (2008) 1.16
Sustainability of Korean National Health Insurance. J Korean Med Sci (2012) 1.14
Midcourse evaluation of the second-term 10-year plan for cancer control in Korea. Asian Pac J Cancer Prev (2011) 1.13
Sociodemographic gradients in breast and cervical cancer screening in Korea: the Korean National Cancer Screening Survey (KNCSS) 2005-2009. BMC Cancer (2011) 1.12
Trends in cervical cancer mortality in Korea 1993-2002: corrected mortality using national death certification data and national cancer incidence data. Int J Cancer (2008) 1.11
Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey (KNCSS), 2004-2010. Cancer Res Treat (2011) 1.09
Liver cancer screening in Korea: a report on the 2008 National Cancer Screening Programme. Asian Pac J Cancer Prev (2010) 1.09
Performance of gastric cancer screening by endoscopy testing through the National Cancer Screening Program of Korea. Cancer Sci (2011) 1.09
Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study. Int J Cancer (2009) 1.08
Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis. Hepatology (2008) 1.08
Prediction of cancer incidence and mortality in Korea, 2011. Cancer Res Treat (2011) 1.06
Locoregional recurrence of breast cancer in patients treated with breast conservation surgery and radiotherapy following neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys (2010) 1.05
Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid. Hepatology (2012) 1.04
Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2011) 1.04
Reproductive and Hormonal Factors Associated with Fatty or Dense Breast Patterns among Korean Women. Cancer Res Treat (2011) 1.03
Application of irregular and unbalanced data to predict diabetic nephropathy using visualization and feature selection methods. Artif Intell Med (2007) 1.03
Factors associated with attending the National Cancer Screening Program for liver cancer in Korea. Asian Pac J Cancer Prev (2012) 1.03
Screening for gastric cancer in Korea: population-based preferences for endoscopy versus upper gastrointestinal series. Cancer Epidemiol Biomarkers Prev (2009) 1.02
Job loss and re-employment of cancer patients in Korean employees: a nationwide retrospective cohort study. J Clin Oncol (2008) 1.02
CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters. Int J Radiat Oncol Biol Phys (2005) 1.02
The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective? Asian Pac J Cancer Prev (2013) 1.00
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR). BMC Cancer (2014) 1.00
Comparing upper gastrointestinal X-ray and endoscopy for gastric cancer diagnosis in Korea. World J Gastroenterol (2010) 0.99
Phase transitions and interrelated instabilities in PbHfO3 single crystals. J Phys Condens Matter (2015) 0.98
Amurensin G, a potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness via down-regulation of multidrug resistance 1. Mol Pharmacol (2010) 0.98
Curative chemoradiotherapy for isolated retroperitoneal lymph node recurrence of colorectal cancer. Radiother Oncol (2010) 0.98
Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer. Radiat Oncol (2011) 0.98
Preoperative short-course concurrent chemoradiation therapy followed by delayed surgery for locally advanced rectal cancer: a phase 2 multicenter study (KROG 10-01). Int J Radiat Oncol Biol Phys (2012) 0.97
Is marital status associated with quality of life? Health Qual Life Outcomes (2014) 0.97
Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J Radiat Oncol Biol Phys (2005) 0.96
Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys (2009) 0.96
Intensity-modulated radiotherapy with a belly board for rectal cancer. Int J Colorectal Dis (2006) 0.96
Long-term trends in cancer mortality in Korea (1983-2007): a joinpoint regression analysis. Asian Pac J Cancer Prev (2010) 0.95
Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea. Asian Pac J Cancer Prev (2013) 0.95
Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? Cancer (2006) 0.95
Predicting the stages of adoption of cervical cancer screening among Korean women. Prev Med (2009) 0.95
Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer. Int J Radiat Oncol Biol Phys (2011) 0.95
Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules. J Korean Med Sci (2012) 0.95
Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer. Hepatology (2011) 0.95
Job satisfaction and trust in Health Insurance Review Agency among Korean physicians. Health Policy (2008) 0.94
Socioeconomic inequalities in completion of hepatitis B vaccine series among Korean women: results from a nationwide interview survey. Vaccine (2012) 0.93
Local excision following pre-operative chemoradiotherapy-induced downstaging for selected cT3 distal rectal cancer. Jpn J Clin Oncol (2010) 0.92
Surgical outcome of pancreatic cancer using radical antegrade modular pancreatosplenectomy procedure. World J Gastroenterol (2012) 0.92
[Participation rate and related socio-demographic factors in the national cancer screening program]. J Prev Med Public Health (2005) 0.91
Predictors and outcomes of feeling of insufficient consultation time in cancer care in Korea: results of a nationwide multicenter survey. Support Care Cancer (2011) 0.91
Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol (2014) 0.91
Patterns of initial disease recurrence after resection of biliary tract cancer. Oncology (2012) 0.91
The association between sleep duration and self-rated health in the Korean general population. J Clin Sleep Med (2013) 0.91
Changes in economic status of households associated with catastrophic health expenditures for cancer in South Korea. Asian Pac J Cancer Prev (2014) 0.91
Cost and effectiveness of the nationwide government-supported Smoking Cessation Clinics in the Republic of Korea. Tob Control (2012) 0.91
Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and therapeutic selection in localized and unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys (2011) 0.90
Increasing uptake of colorectal cancer screening in Korea: a population-based study. BMC Public Health (2010) 0.90
Meta-analysis of the effects of beta blocker on survival time in cancer patients. J Cancer Res Clin Oncol (2014) 0.90
Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis. Free Radic Biol Med (2009) 0.90
Who participates in the gastric cancer screening and on-time rescreening in the National Cancer Screening Program? A population-based study in Korea. Cancer Sci (2011) 0.90
Extent of thyroidectomy affects vocal and throat functions: a prospective observational study of lobectomy versus total thyroidectomy. Surgery (2013) 0.90
Comparison of uncovered and covered stents for the treatment of malignant duodenal obstruction caused by pancreaticobiliary cancer. Surg Endosc (2013) 0.89
Characteristics of movement-induced dose reduction in target volume: a comparison between photon and proton beam treatment. Med Dosim (2008) 0.89
Factors associated with organized and opportunistic cancer screening: Results of the Korea National Health and Nutrition Examination Survey (KNHANES) 2007-2011. Asian Pac J Cancer Prev (2014) 0.89
Biochemically-verified smoking rate trends and factors associated with inaccurate self-reporting of smoking habits in Korean women. Asian Pac J Cancer Prev (2013) 0.89
Phase II trial of proton beam accelerated partial breast irradiation in breast cancer. Radiother Oncol (2013) 0.89
[Effects of private health insurance on health care utilization and expenditures in Korean cancer patients: focused on 5 major cancers in one cancer center]. J Prev Med Public Health (2007) 0.89
Primary malignant teratoma with a primitive neuroectodermal tumor component in thyroid gland: a case report. J Korean Med Sci (2007) 0.89
CpG methylation modulates tissue-specific expression of a transgene in chickens. Theriogenology (2010) 0.89
Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis. Gynecol Oncol (2006) 0.89
Cascaded spiral microfluidic device for deterministic and high purity continuous separation of circulating tumor cells. Biomicrofluidics (2014) 0.88